Enhancer	O
-	O
blocking	O
activity	O
is	O
associated	O
with	O
hypersensitive	O
site	O
V	O
sequences	O
in	O
the	O
human	O
growth	O
hormone	O
locus	O
control	O
region	O
.	O


Activation	O
of	O
the	O
human	O
growth	O
hormone	O
gene	O
(	O
hGH	O
-	O
N	O
)	O
is	O
linked	O
to	O
a	O
locus	O
control	O
region	O
(	O
LCR	O
)	O
containing	O
four	O
(	O
I	O
-	O
III	O
,	O
V	O
)	O
hypersensitive	O
sites	O
(	O
HS	O
)	O
.	O


Pit	O
-	O
1	O
binding	O
to	O
HS	O
I	O
/	O
II	O
is	O
required	O
for	O
efficient	O
pituitary	O
expression	O
.	O


However	O
,	O
inclusion	O
of	O
HS	O
III	O
and	O
V	O
,	O
located	O
about	O
28	O
and	O
32	O
kb	O
upstream	O
of	O
the	O
hGH	O
-	O
N	O
gene	O
,	O
respectively	O
,	O
is	O
also	O
required	O
for	O
consistent	O
hGH	O
-	O
N	O
expression	O
levels	O
in	O
vivo	O
.	O


HS	O
V	O
is	O
referred	O
to	O
as	O
a	O
boundary	O
for	O
the	O
hGH	O
LCR	O
,	O
but	O
no	O
specific	O
enhancer	O
blocking	O
or	O
barrier	O
function	O
is	O
reported	O
.	O


We	O
examined	O
a	O
547	O
bp	O
fragment	O
containing	O
HS	O
V	O
sequences	O
(	O
nucleotides	O
-	O
32	O
,	O
718	O
/	O
-	O
32	O
,	O
172	O
relative	O
to	O
hGH	O
-	O
N	O
)	O
for	O
enhancer	O
-	O
blocking	O
activity	O
using	O
a	O
well	O
-	O
established	O
transient	O
gene	O
transfer	O
system	O
and	O
assessed	O
these	O
sequences	O
for	O
CCCTC	O
binding	O
factor	O
(	O
CTCF	O
)	O
,	O
which	O
is	O
linked	O
to	O
enhancer	O
-	O
blocking	O
activity	O
.	O


The	O
547	O
bp	O
HS	O
V	O
fragment	O
decreased	O
enhancer	O
activity	O
with	O
a	O
reverse	O
-	O
orientation	O
preference	O
when	O
inserted	O
between	O
HS	O
III	O
enhancer	O
sequences	O
and	O
a	O
minimal	O
thymidine	O
kinase	O
promoter	O
(	O
TKp	O
)	O
.	O


These	O
sequences	O
are	O
associated	O
with	O
CTCF	O
in	O
human	O
pituitary	O
and	O
nonpituitary	O
chromatin	O
.	O


Enhancer	O
-	O
blocking	O
activity	O
with	O
an	O
orientation	O
preference	O
was	O
further	O
localized	O
to	O
a	O
45	O
bp	O
sub	O
-	O
fragment	O
,	O
with	O
evidence	O
of	O
CTCF	O
and	O
upstream	O
binding	O
factor	O
1	O
(	O
USF1	O
)	O
binding	O
;	O
USF1	O
is	O
linked	O
more	O
closely	O
with	O
barrier	O
function	O
.	O


The	O
presence	O
of	O
yin	O
and	O
yang	O
1	O
(	O
Yy1	O
)	O
that	O
cooperates	O
with	O
CTCF	O
in	O
the	O
regulation	O
of	O
X	O
-	O
chromosome	O
inactivation	O
was	O
also	O
seen	O
.	O


A	O
decrease	O
in	O
CTCF	O
and	O
Yy1	O
RNA	O
levels	O
was	O
associated	O
with	O
a	O
significant	O
reduction	O
in	O
enhancer	O
-	O
blocking	O
activity	O
.	O


Assessment	O
of	O
CpG	O
-	O
dinucleotides	O
in	O
the	O
TKp	O
indicates	O
that	O
the	O
presence	O
of	O
HS	O
V	O
sequences	O
are	O
associated	O
with	O
an	O
increased	O
incidence	O
of	O
CpG	O
-	O
dinucleotide	O
methylation	O
of	O
the	O
GC	O
box	O
region	O
.	O


These	O
data	O
support	O
association	O
of	O
CTCF	O
and	O
enhancer	O
-	O
blocking	O
activity	O
with	O
HS	O
V	O
that	O
is	O
consistent	O
with	O
a	O
role	O
as	O
a	O
(	O
LCR	O
)	O
boundary	O
element	O
and	O
also	O
implicates	O
Yy1	O
in	O
this	O
process	O
.	O
